249 related articles for article (PubMed ID: 6145676)
21. Gastric antisecretory and pharmacologic properties of N,N-dimethyl-N'-(2-diisopropylaminoethyl)-N-(4,6-dimethyl-2-pyridyl)ur ea (L-634,366).
Torchiana ML; Cook PG; Hanson CA; Wesley CA; Westrick BL; Wiese SR; Risley EA; Williams M
Arch Int Pharmacodyn Ther; 1986 May; 281(1):120-33. PubMed ID: 2875693
[TBL] [Abstract][Full Text] [Related]
22. Histamine H2-receptor antagonistic action of N-(3-[3-(1-piperidinylmethyl)phenoxy]propyl)acetoxyacetamide hydrochloride (TZU-0460).
Tarutani M; Sakuma H; Shiratsuchi K; Mieda M
Arzneimittelforschung; 1985; 35(4):703-6. PubMed ID: 2861823
[TBL] [Abstract][Full Text] [Related]
23. Effects of FRG-8701 on gastric acid secretion, gastric mucosal lesions by necrotizing agents and experimental gastric or duodenal ulcer in rats.
Shibata M; Yamaura T; Sekine A; Nishikawa M; Chida Y; Ohnishi H
Jpn J Pharmacol; 1990 Nov; 54(3):277-85. PubMed ID: 1982548
[TBL] [Abstract][Full Text] [Related]
24. Mucosal protective action of histamine against gastric lesions induced by HCl in rats: importance of antigastric motor activity mediated by H2-receptors.
Takeuchi K; Nishiwaki H; Okada M; Okabe S
J Pharmacol Exp Ther; 1988 May; 245(2):632-8. PubMed ID: 2966857
[TBL] [Abstract][Full Text] [Related]
25. The antisecretory profile of action of the H2-receptor antagonists, famotidine, loxtidine, ranitidine and L-643,441 on the rat isolated gastric mucosa.
Reeves JJ; Stables R
Agents Actions; 1987 Feb; 20(1-2):22-8. PubMed ID: 2883848
[TBL] [Abstract][Full Text] [Related]
26. Comparative study with oxmetidine and ranitidine on acid secretion and gastrin release in the dog.
Soldani G; Del Tacca M; Polloni A; Bernardini C; Martinotti E
Int J Tissue React; 1984; 6(2):181-4. PubMed ID: 6145677
[TBL] [Abstract][Full Text] [Related]
27. Antisecretory effects of two new histamine H2-receptor antagonists.
Bickel M; Herling AW; Rising TJ; Wirth K
Arzneimittelforschung; 1986 Sep; 36(9):1358-63. PubMed ID: 2878669
[TBL] [Abstract][Full Text] [Related]
28. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
[TBL] [Abstract][Full Text] [Related]
29. Kinetics of antisecretory action of a new H2-antagonist, YM-11170, in conscious dogs.
Takeda M; Takagi T; Maeno H
Eur J Pharmacol; 1983 Aug; 91(4):371-6. PubMed ID: 6137398
[TBL] [Abstract][Full Text] [Related]
30. [Gastric acid secretion and histamine H2 receptor antagonists].
Gespach C; Emami S; Di Gioia Y; Chastre E
Gastroenterol Clin Biol; 1990; 14(12):982-94. PubMed ID: 1981198
[No Abstract] [Full Text] [Related]
31. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
Amagase K; Kato S; Yamamoto H; Okabe S
Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the effects of structurally different H2-antagonists on acid and pepsin activity stimulated by dimaprit in conscious cats.
Impicciatore M; Chiavarini M; Morini G; Barocelli E; Molina E; Plazzi PV
Agents Actions; 1985 Sep; 16(6):496-500. PubMed ID: 2866688
[TBL] [Abstract][Full Text] [Related]
33. Effect of the novel histamine H2-antagonist 5,6-dimethyl-2-[4-[3-(1- piperidinomethyl)phenoxy]-(z)-2-butenylamino]-4(1H)-pyrimidine dihydrochloride on histamine-induced gastric acid secretion in Heidenhain pouch dogs.
Uchida M; Ohba S; Ikarashi Y; Misaki N; Kawano O
Arzneimittelforschung; 1993 Aug; 43(8):873-6. PubMed ID: 8105784
[TBL] [Abstract][Full Text] [Related]
34. Effects of the new anti-ulcer drug nizatidine on prostaglandins in the rat gastric mucosa.
Segawa Y; Takei M; Omata T; Tsuzuike N; Yamaji Y; Kurimoto T; Ozeki M; Tagashira E
Arzneimittelforschung; 1991 Sep; 41(9):950-3. PubMed ID: 1796923
[TBL] [Abstract][Full Text] [Related]
35. Studies on the cytoprotective and antisecretory activity of ebrotidine. A review.
Konturek PC; Brzozowski T; Konturek SI; Márquez M; Torres J; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):578-89. PubMed ID: 9205769
[TBL] [Abstract][Full Text] [Related]
36. Structural modification of H2-receptor antagonists provide post-H2-receptor gastric antisecretory activity.
Nielsen ST; Dove PA; Strike DP; Schiehser GA
Drugs Exp Clin Res; 1987; 13(5):297-304. PubMed ID: 2890506
[TBL] [Abstract][Full Text] [Related]
37. Action of stobadine on respiratory and vascular smooth muscle in vivo: evidence for histamine receptor antagonist activity.
Bauer V; Buran L; Babul'ová A
Arch Int Pharmacodyn Ther; 1990; 304():232-46. PubMed ID: 1978643
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological profiles of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy] propyl] urea.
Sekiguchi H; Hamada K; Kobayashi F; Taga F; Uchida H
Arzneimittelforschung; 1993 Feb; 43(2):129-33. PubMed ID: 8096132
[TBL] [Abstract][Full Text] [Related]
39. Actions of nizatidine, a selective histamine H2-receptor antagonist, on gastric acid secretion in dogs, rats and frogs.
Lin TM; Evans DC; Warrick MW; Pioch RP
J Pharmacol Exp Ther; 1986 Nov; 239(2):406-10. PubMed ID: 2877081
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and pharmacology of two new histamine receptor antagonists related to ranitidine.
Navarro JJ; Almeida JF; Anaya J; Moran JR; Grande M; Caballero MC; Palacios B; Montero MJ; San Roman L
Pharmazie; 1995 Jan; 50(1):12-5. PubMed ID: 7886119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
